Janssen Search
Search results
Grants & Giving
“We are responsible to the communities in which we live and work.” Our Responsibilities Guide Our Charitable Giving Article Type: Grants Giving Our responsibilities, as set forth in Our Credo, guide Janssen's charitable giving. In administering our ...
Oral Cavity and Oropharyngeal /Cervical Cancer
Article Block Text: Diagnosing pre-cancer early to intercept disease with precision solutions. Article Type: Disease Interception Accelerator Oral Cavity & Oropharyngeal Cancer/Cervical Cancer Developing risk-assessment processes, diagnostics and ...
Innovating HIV Treatment and Prevention
Innovating HIV Treatment and Prevention Expanding Access to HIV Treatment is a Top Global Public Health Priority Janssen is exploring innovative applications of our HIV medicines to help address treatment and prevention outcomes in hard-to-reach areas by ...
Living the Principles of Green Chemistry
Living the Principles of Green Chemistry Our series on green chemistry continues with an exploration of how we at Janssen approach and activate these vital principles. Click here for a primer on green chemistry, and watch this space for additional ...
Pediatric HIV Donation
Improving Access for Children Living with HIV At Janssen, we are dedicated to doing our part to help children and young people living with HIV thrive and reach adulthood. Our company has a long history of working to improve the lives and well-being of ...
Transparency and Collaboration
Transparency and Collaboration At Janssen, we believe transparency helps to advance science and medicine; it’s in the best interests of both the people who use our pharmaceutical products and providers who prescribe them. The people and healthcare ...
Discoveries in Immunology Disease Treatment
Discovery: Embracing New Ideas to Build a Promising Pipeline for the Future Submerged monolayer culture of colonic epithelial cells More than two decades ago, our scientists pioneered the use of antibodies to tumor necrosis factor (TNF)-alpha to treat ...
Eric Schaeffer, Ph.D.
ERIC SCHAEFFER, PH.D. SENIOR DIRECTOR NEUROSCIENCE INNOVATION BOSTON INNOVATION CENTER Eric Schaeffer, Ph.D. received his degree from the Albert Einstein College of Medicine in New York City, and went on to do post-doctoral fellowships at the ...
Christopher Stevenson Ph.D.
As the Chronic Obstructive Pulmonary Disease (COPD) Venture Leader for the Disease Interception Accelerator (DIA), Christopher leads efforts focused on pinpointing individuals who are at risk and in the earliest stages of COPD using radiology and ...
Contact Us
Thank you for your interest in learning more about Janssen. We care about your questions and concerns. Adverse Event/Product Quality Complaint Reporting If you would like to report an Adverse Event (medication side effect) and/or Product Quality ...